Ilyés István
Debreceni Egyetem, Általános Orvostudományi Kar Gyermekgyógyászati Intézet, Endokrin Szakrendelés Debrecen Nagyerdei krt. 98. 4032.
Orv Hetil. 2011 Apr 17;152(16):617-27. doi: 10.1556/OH.2011.29088.
In recent years our knowledge on thyroid diseases in childhood has been increased. Several forms of congenital hypothyroidism (dysgenesis, dyshormongenesis, thyrotropin resistance and some central forms) are consequences of gene mutations. Maternal hypothyroxinemia due to severe iodine deficiency leads to early neurological damage and congenital hypothyroidism. Neonatal screening of congenital hypothyroidism and early treatment with l-thyroxin ensure good prognosis. Differential diagnosis of the various forms of congenital hypothyroidism in newborns is not an easy task. The need for treatment of transient hypothyroxinemia is still controversial. Diagnosis of juvenile lymphocytic thyroiditis can be ascertained by the clinical status, ultrasound examination, detection of anti-peroxydase antibodies, evaluation of thyroid function, and fine needle aspiration cytology. L-thyroxin therapy is recommended in cases of subclinical and manifest hypothyroidism. The transient form of the rare newborn hyperthyroidism is the consequence of maternal Graves-Basedow disease. It can be a sever condition and its permanent form is caused by TSH-receptor gene mutation. In the pathogenesis of autonomic thyroid adenoma mutations of the TSH-receptor and the alpha subunit of the stimulatory G-protein are involved. Treatment of Graves-Basedow disease in childhood is a debated question. The first choice is medical treatment with antithyroid and beta-blocking drugs. However, remission rate is low under this therapy, and the disease is characterised by frequent relapses. For this reason, the necessity of definitive therapy frequently arises. In Europe subtotal thyroidectomy is used as second choice of therapy, but clinical experience in the United States showed that radioiodine treatment is a safe and effective therapy for children and adolescents. Iodine deficient goitre in childhood is a form of iodine deficiency disorder. It is the consequence of adaptation to iodine deficiency. It can be treated by iodine or/and l-thyroxin, and its development can be prevented by iodinated salt. In childhood, thyroid nodule needs for a detailed investigation because of the possibility of thyroid cancer. Medullar thyroid carcinoma indicates genetic screening in the patients and their family, and the presence of disease-causing RET-proto-oncogene mutation confirms the need for total thyroidectomy already in childhood.
近年来,我们对儿童甲状腺疾病的认识有所增加。几种先天性甲状腺功能减退症(甲状腺发育不全、甲状腺激素合成障碍、促甲状腺激素抵抗及一些中枢性类型)是基因突变的结果。严重碘缺乏导致的母体甲状腺素血症会引起早期神经损伤和先天性甲状腺功能减退症。先天性甲状腺功能减退症的新生儿筛查及左甲状腺素早期治疗可确保良好预后。新生儿各种先天性甲状腺功能减退症的鉴别诊断并非易事。短暂性甲状腺素血症是否需要治疗仍存在争议。青少年淋巴细胞性甲状腺炎的诊断可通过临床症状、超声检查、抗过氧化物酶抗体检测、甲状腺功能评估及细针穿刺细胞学检查来确定。亚临床和显性甲状腺功能减退症病例建议采用左甲状腺素治疗。罕见的新生儿甲亢的短暂形式是母体格雷夫斯-巴塞多病的结果。它可能是一种严重病症,其永久性形式由促甲状腺激素受体基因突变引起。自主性甲状腺腺瘤的发病机制涉及促甲状腺激素受体和刺激性G蛋白α亚基的突变。儿童格雷夫斯-巴塞多病的治疗是一个有争议的问题。首选是使用抗甲状腺药物和β受体阻滞剂进行药物治疗。然而,这种治疗的缓解率较低,且该疾病的特点是频繁复发。因此,经常需要进行确定性治疗。在欧洲,甲状腺次全切除术用作第二线治疗选择,但美国的临床经验表明,放射性碘治疗对儿童和青少年是一种安全有效的治疗方法。儿童碘缺乏性甲状腺肿是碘缺乏病的一种形式。它是对碘缺乏适应的结果。可通过碘或/和左甲状腺素进行治疗,碘化盐可预防其发生。儿童甲状腺结节因有可能是甲状腺癌而需要进行详细检查。甲状腺髓样癌需对患者及其家族进行基因筛查,致病的RET原癌基因突变的存在证实儿童期就已需要进行甲状腺全切术。